Cameco Shares Slip by 0.08% with 295th Highest Trading Volume, Yet Analyst Confidence Grows on Institutional Purchases and India Agreement

Cameco Market Overview

As of March 12, 2026, Cameco (CCJ) ended the trading session with a slight loss of 0.08%, closing at about $115.37 per share. The day's trading volume reached $460 million, placing it 295th in market activity rankings. Despite this modest dip, Cameco's share price remains close to its 52-week peak of $135.24, and the company holds a market capitalization of roughly $50.3 billion. The latest quarterly report, released on February 13, revealed stronger-than-expected results: earnings per share came in at $0.36, beating the consensus estimate of $0.29, while revenue totaled $874.6 million, surpassing projections of $782.1 million.

Main Factors Influencing Performance

Cameco's recent share price movement is shaped by a combination of increased institutional investment, solid financial results, and a major new supply contract, despite the minor recent pullback.

Institutional Investors Show Strong Support

Institutional investors currently control 70.21% of Cameco's outstanding shares. Notably, Connor Clark & Lunn Investment Management Ltd. boosted its holdings by 32.8% in the third quarter, acquiring an additional 1,060,842 shares for a total of 4,291,202 shares valued at $360.1 million, making Cameco its 16th-largest position. Other significant investors, such as Barometer Capital Management Inc. (which increased its stake by 28.6%) and Franklin Resources Inc. (up 10.8%), have also expanded their positions. This collective buying activity reflects growing confidence in Cameco's long-term outlook, especially as global interest in uranium and nuclear power accelerates amid geopolitical shifts and the rise of AI-driven industries.

Strong Earnings and Positive Analyst Sentiment

Cameco's most recent quarter demonstrated operational resilience, with revenue rising 1.5% year-over-year to $874.6 million and a net margin of 17%. The company’s $0.36 EPS outpaced expectations, highlighting improved operational efficiency and favorable uranium pricing. Analysts remain largely optimistic, with 13 recommending “Buy” and 2 suggesting “Hold,” resulting in a consensus rating of “Moderate Buy” and an average price target of $150.40. Noteworthy upgrades include Royal Bank of Canada increasing its target to $160 and Canadian Imperial Bank of Commerce setting a new high at $202. These projections are fueled by expectations of continued uranium price increases and Cameco’s strategic role in the evolving energy landscape.

Major Supply Deal with India and Geopolitical Momentum

A significant milestone for Cameco was the announcement on March 4 of a $2.6 billion, nine-year uranium supply agreement with India. Under this contract, Cameco will provide 22 million pounds of uranium between 2027 and 2035, positioning the company as a key supplier to India’s rapidly growing nuclear sector. India’s ambition to expand its nuclear capacity to 100 gigawatts by 2047 aligns with global trends toward cleaner energy. Analysts see this agreement as a driver for stable long-term revenue and increased market share, especially as geopolitical factors and the demand for nuclear energy in the AI era contribute to what some call a “nuclear supercycle.”

Market Trends and Analyst Price Targets

Despite strong fundamentals, Cameco’s shares finished slightly lower on March 12, trading just under the 50-day moving average of $115.89. This minor decline may be attributed to broader market fluctuations or profit-taking after a 135% rally over the past year. The company’s trailing P/E ratio stands at 118.94, with a forward P/E of 119.95, indicating that investors are factoring in continued growth. While firms like Goldman Sachs and Raymond James maintain “Buy” ratings, others have shifted from “Strong-Buy” to “Hold,” reflecting a generally positive but somewhat cautious stance.

Summary

Cameco’s share price is being propelled by robust institutional backing, strong earnings performance, and strategic contracts in expanding markets. Although the recent dip suggests some short-term caution, the company’s solid fundamentals—including a 17% net margin, rising uranium demand, and a diversified investor base—support its prospects for sustained growth. With an average analyst target of $150.40 and a market cap near $50.3 billion, Cameco is well-positioned to benefit from the global shift toward nuclear energy and the ongoing nuclear supercycle.